Pyrimidinol-based inhibitor of MAP4K4 for myocardial infarction

DISEASE CATEGORY: Cardiovascular

INDICATION: Myocardial infarction (MI)

Patient sample, in vitro, cell culture and mouse studies identified a pyrimidinol-based

Read the full 170 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE